Premier Biomedical BIEI Stock
Premier Biomedical Price Chart
Premier Biomedical BIEI Financial and Trading Overview
| Premier Biomedical stock price | 0.0011 USD |
| Previous Close | 0.0013 USD |
| Open | 0.0012 USD |
| Bid | 0.0011 USD x 694003400 |
| Ask | 0.0012 USD x 88340000 |
| Day's Range | 0.0012 - 0.0013 USD |
| 52 Week Range | 0.0003 - 0.002 USD |
| Volume | 3M USD |
| Avg. Volume | 23.89M USD |
| Market Cap | 1.68M USD |
| Beta (5Y Monthly) | 0.651 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BIEI Valuation Measures
| Enterprise Value | 1.24M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 117.63721 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 86.945 |
| Enterprise Value/EBITDA | -3.833 |
Trading Information
Premier Biomedical Stock Price History
| Beta (5Y Monthly) | 0.651 |
| 52-Week Change | 140.00% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.002 USD |
| 52 Week Low | 0.0003 USD |
| 50-Day Moving Average | 0.000872 USD |
| 200-Day Moving Average | 0.00072 USD |
BIEI Share Statistics
| Avg. Volume (3 month) | 23.89M USD |
| Avg. Daily Volume (10-Days) | 25.48M USD |
| Shares Outstanding | 1.4B |
| Float | 976.3M |
| Short Ratio | N/A |
| % Held by Insiders | 2.36% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:250 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2019 |
| Most Recent Quarter (mrq) | December 31, 2019 |
| Next Fiscal Year End | December 31, 2020 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -8196.55% |
| Gross Margin | 9.95% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -153.58% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 14.28K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | -85.59% |
| Gross Profit (ttm) | 1.42K USD |
| EBITDA | -323905 USD |
| Net Income Avi to Common (ttm) | -374470 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 71.2K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 160.75K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.048 |
| Book Value Per Share (mrq) | -0.007 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -344180 USD |
| Levered Free Cash Flow (ttm) | -310456 USD |
Profile of Premier Biomedical
| Country | United States |
| State | PA |
| City | Jackson Center |
| Address | PO Box 25 |
| ZIP | 16133 |
| Phone | 724 633 7033 |
| Website | https://www.premierbiomedical.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer's disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Q&A For Premier Biomedical Stock
What is a current BIEI stock price?
Premier Biomedical BIEI stock price today per share is 0.0011 USD.
How to purchase Premier Biomedical stock?
You can buy BIEI shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Premier Biomedical?
The stock symbol or ticker of Premier Biomedical is BIEI.
Which industry does the Premier Biomedical company belong to?
The Premier Biomedical industry is Drug Manufacturers - Specialty & Generic.
How many shares does Premier Biomedical have in circulation?
The max supply of Premier Biomedical shares is 1.4B.
What is Premier Biomedical Price to Earnings Ratio (PE Ratio)?
Premier Biomedical PE Ratio is now.
What was Premier Biomedical earnings per share over the trailing 12 months (TTM)?
Premier Biomedical EPS is -0.01 USD over the trailing 12 months.
Which sector does the Premier Biomedical company belong to?
The Premier Biomedical sector is Healthcare.